Holen Sie sich die Stockscreener-App
6.185
0.48%
-0.035
Schlusskurs vom Vortag:
$6.22
Offen:
$6.19
24-Stunden-Volumen:
3,240
Relative Volume:
0.01
Marktkapitalisierung:
$168.43M
Einnahmen:
$331.52M
Nettoeinkommen (Verlust:
$-52.69M
KGV:
-2.7489
EPS:
-2.25
Netto-Cashflow:
$-14.47M
1W Leistung:
-1.90%
1M Leistung:
+0.98%
6M Leistung:
-27.69%
1J Leistung:
-19.82%
1-Tages-Spanne:
$6.185
$6.20
1-Wochen-Bereich:
$6.12
$6.72
52-Wochen-Spanne:
$5.3401
$9.13
Inogen Inc Stock (INGN) Company Profile
Firmenname
Inogen Inc
Sektor
Branche
Telefon
805-562-0500
Adresse
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.185 | 173.20M | 331.52M | -52.69M | -14.47M | -2.25 |
|
ABT
Abbott Laboratories
|
110.19 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
357.80 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
90.08 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
70.05 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.50 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | B. Riley Securities | Buy |
| 2025-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-02-15 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Herabstufung | Needham | Buy → Hold |
| 2023-01-17 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Hochstufung | Needham | Hold → Buy |
| 2021-11-02 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Herabstufung | Needham | Buy → Hold |
| 2020-05-06 | Bestätigt | Needham | Buy |
| 2019-11-06 | Hochstufung | Needham | Hold → Buy |
| 2019-09-13 | Bestätigt | Piper Jaffray | Overweight |
| 2019-08-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Herabstufung | Stifel | Buy → Hold |
| 2019-08-07 | Herabstufung | Needham | Buy → Hold |
| 2019-06-28 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Bestätigt | Needham | Strong Buy |
| 2019-02-27 | Bestätigt | Needham | Strong Buy |
| 2018-11-20 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-11-07 | Bestätigt | Needham | Buy |
| 2018-09-10 | Herabstufung | Needham | Strong Buy → Buy |
| 2018-08-22 | Fortgesetzt | Stifel | Buy |
| 2018-08-08 | Bestätigt | Needham | Strong Buy |
| 2018-06-06 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Bestätigt | Needham | Strong Buy |
| 2018-02-28 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Inogen Inc Aktie (INGN) Neueste Nachrichten
Exit Recap: What are the risks of holding Inogen IncJuly 2025 Final Week & AI Enhanced Trading Signals - baoquankhu1.vn
Earnings Beat: Is Inogen Inc a turnaround storyJuly 2025 Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum - The AI Journal
Comparing Neuronetics (NASDAQ:STIM) & Inogen (NASDAQ:INGN) - Defense World
Inogen, Inc (NASDAQ:INGN) Short Interest Update - MarketBeat
Inogen Earnings Call Shows Turnaround Amid Mixed Headwinds - TipRanks
[Form 4] Inogen Inc Insider Trading Activity - Stock Titan
Inogen (NASDAQ: INGN) EVP reports RSU grant, vesting and tax disposals - Stock Titan
Inogen (INGN) CCO reports RSU vesting and 20,000-unit grant - Stock Titan
Inogen (INGN) EVP Kevin P. Smith reports RSU grants and tax share withholding - Stock Titan
Inogen (NASDAQ: INGN) CFO logs RSU vesting, share tax withholdings - Stock Titan
Inogen (INGN) CEO receives 90,000 RSU grant and reports tax share withholdings - Stock Titan
INGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Revenue Check: Whats the beta of Inogen Inc stock2025 Retail Activity & Growth Focused Investment Plans - baoquankhu1.vn
What’s the beta of Inogen Inc. stock2025 Price Momentum & Daily Price Action Insights - mfd.ru
Inogen (NASDAQ: INGN) outlines 2025 revenue mix and respiratory growth strategy - Stock Titan
Inogen, Inc. (NASDAQ:INGN) Q4 2025 Earnings Call Transcript - Insider Monkey
Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y - sharewise.com
Risk Report: How do insiders feel about Inogen IncWeekly Trade Analysis & Risk Controlled Daily Plans - baoquankhu1.vn
Celebrating 25 Years of Inogen Alliance: A Milestone in Global EHS & Sustainability Leadership - Morningstar
Portfolio Update: Does Inogen Inc have pricing powerPortfolio Profit Report & Low Drawdown Momentum Ideas - baoquankhu1.vn
Inogen, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Inogen authorizes $30 million stock buyback program - Investing.com India
Inogen GAAP net loss hits USD 7.1M in Q4 2025 - Medical Buyer
Inogen Announces $30 Million Share Repurchase Program - BioSpace
Inogen Inc earnings beat by $0.07, revenue fell short of estimates - Investing.com Australia
Inogen Inc (INGN) Q4 2025 Earnings Call Highlights: Revenue Grow - GuruFocus
Inogen Q4 Earnings Call Highlights - MarketBeat
Inogen (INGN) Projects Revenue Growth in 2026 Forecast - GuruFocus
Inogen (INGN) Projects Flat Revenue for Q1 2026 - GuruFocus
Inogen authorizes $30 million stock buyback program By Investing.com - Investing.com Australia
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Inogen (INGN) Reports Growth with Positive EBITDA in Q4 - GuruFocus
Inogen Inc (NASDAQ:INGN) Stock Falls on Revenue Miss and Cautious 2026 Outlook - ChartMill
Inogen (INGN) Initiates $30 Million Share Buyback Program - GuruFocus
Inogen, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:INGN) 2026-02-24 - Seeking Alpha
Inogen: Q4 Earnings Snapshot - Barchart.com
Inogen Posts 2025 Results and Launches Share Buyback - TipRanks
Inogen Q4 revenue rises - TradingView
Inogen (NASDAQ:INGN) Releases Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
Inogen : Supplemental Financials FY 2025 - marketscreener.com
Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook - marketscreener.com
Inogen, Inc. announces an Equity Buyback for $30 million worth of its shares. - marketscreener.com
Inogen (INGN) lifts 2025 results and OKs $30M share repurchase plan - Stock Titan
Inogen, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026 - marketscreener.com
Inogen Inc recently announced its revenue forecast for fiscal year 2026. - Bitget
Inogen: Fourth Quarter Financial Overview - Bitget
Inogen launches Aurora CPAP masks in the U.S. - American Academy of Sleep Medicine | AASM
Inogen Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
EV Market: Does NVNIW have strong EBITDA marginsExit Point & Reliable Price Breakout Signals - baoquankhu1.vn
Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline - Finviz
Finanzdaten der Inogen Inc-Aktie (INGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
1.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):